Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitolisant versus placebo in narcolepsy with cataplexy
2012-003076-39Phase 3Completed
- Sponsor
- Bioprojet
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in narcolepsy type 1 (NT1) comparing Pitolisant with Placebo (2 arms). Primary endpoint: Change in average number of cataplexy attacks per week. Started Aug 2012; status: completed.
02
Drugs
pitolisant
03
Conditions
narcolepsy type 1 (NT1)
Beyond the preview
Go deeper on 2012-003076-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003076-39.